newsPersonalised cancer immunotherapy granted fast track designation23 January 2023 | By Catherine Eckford (European Pharmaceutical Review)The FDA has granted fast track designation for Evaxion’s personalised cancer vaccine in combination Keytruda® for patients with metastatic melanoma.